BFM
CLVS

Boothbay Fund Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Boothbay Fund Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-36,350
Closed -$43K – 2689
2022
Q3 		$43K Sell
36,350
-18,531
-34% -$28.9K ﹤0.01% 2129
2022
Q2 		$99K Sell
54,881
-41,178
-43% -$60.7K ﹤0.01% 1988
2022
Q1 		$194K Sell
96,059
-15,459
-14% -$30.4K ﹤0.01% 1898
2021
Q4 		$302K Hold
111,518
– – 0.01% 1252
2021
Q3 		$497K Sell
111,518
-16,804
-13% -$80.9K 0.01% 1089
2021
Q2 		$744K Buy
128,322
+50,120
+64% +$294K 0.02% 830
2021
Q1 		$549K Buy
78,202
+9,088
+13% +$60.9K 0.02% 895
2020
Q4 		$332K Sell
69,114
-12,284
-15% -$62.1K 0.01% 915
2020
Q3 		$475K Buy
+81,398
New +$487K 0.03% 659
2020
Q2 		– Sell
-31,100
Closed -$198K – 1147
2020
Q1 		$198K Buy
+31,100
New +$249K 0.02% 667
2019
Q3 		– Sell
-58,241
Closed -$866K – 953
2019
Q2 		$866K Buy
58,241
+8,188
+16% +$148K 0.08% 295
2019
Q1 		$1.24M Buy
+50,053
New +$1.25M 0.12% 190
2017
Q3 		– Sell
-2,567
Closed -$204K – 818
2017
Q2 		$240K Buy
+2,567
New +$157K 0.05% 494

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Boothbay Fund Management's CLVS Position: Q4 2022 in Review

Boothbay Fund Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 36,350 shares — an estimated $43K sold.

Boothbay Fund Management first reported a position in CLVS in Q2 2017 and held it in 13 quarters. The position peaked at $1.24M in Q1 2019. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • Boothbay Fund Management reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • Boothbay Fund Management sold 36,350 Clovis Oncology, Inc. shares in Q4 2022, an estimated $43K.
  • Boothbay Fund Management first reported a position in Clovis Oncology, Inc. in Q2 2017 and held it in 13 quarters.
  • Boothbay Fund Management's Clovis Oncology, Inc. position peaked at $1.24M in Q1 2019.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Boothbay Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.